Erratum: Afshinnia F, Rajendiran TM, Karnovsky A, et al. Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort. Kidney Int Rep. 2016;1:256–268 (S2468024916300596) (10.1016/j.ekir.2016.08.007));Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort

Kidney International Reports

Volumn 1, Issue 4, 2016, Pages 256-268

  Afshinnia, Farsad ^a   Rajendiran, Thekkelnaycke M ^a,b   Karnovsky, Alla ^a,b   Soni, Tanu ^b   Wang, Xue ^c   Xie, Dawei ^c   Yang, Wei ^c   Shafi, Tariq ^d   Weir, Matthew R ^e   He, Jiang ^f   Brecklin, Carolyn S ^g   Rhee, Eugene P ^h   Schelling, Jeffrey R ⁱ   Ojo, Akinlolu ^a   Feldman, Harold ^c   Michailidis, George ^j   Pennathur, Subramaniam ^a,b   Appel, Lawrence J ^k   Go, Alan S ^k   Kusek, John W ^k   Lash, James P ^k   Townsend, Raymond R ^k   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Michigan Regional Comprehensive Metabolomics Resource Core   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ METROHEALTH MEDICAL CENTER   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k NONE

more..

Author keywords

chronic kidney disease; lipids; proteinuria

Indexed keywords

EID: 84995564790     PISSN: 24680249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ekir.2017.09.002     Document Type: Erratum

References (55)

1. 1 Centers for Disease Control. National Chronic Kidney Disease Fact Sheet 2010. Available at: www.cdc.gov/diabetes/projects/pdfs/ckd_summary.pdf. Accessed September 8, 2016.
2. 2 Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
3. 3 Rule, A.D., Larson, T.S., Bergstralh, E.J., et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004), 929–937.
4. 4 Fahy, E., Subramaniam, S., Murphy, R.C., et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 50:suppl (2009), S9–S14.
5. 5 Subramaniam, S., Fahy, E., Gupta, S., et al. Bioinformatics and systems biology of the lipidome. Chem Rev 111 (2011), 6452–6490.
6. 6 Chawla, V., Greene, T., Beck, G.J., et al. Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol 5 (2010), 1582–1587.
7. 7 Hadjadj, S., Duly-Bouhanick, B., Bekherraz, A., et al. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 30 (2004), 43–51.
8. 8 Kaysen, G.A., Lipid and lipoprotein metabolism in chronic kidney disease. J Ren Nutr 19 (2009), 73–77.
9. 9 Rahman, M., Yang, W., Akkina, S., et al. Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study. Clin J Am Soc Nephrol 9 (2014), 1190–1198.
10. 10 Samuelsson, O., Mulec, H., Knight-Gibson, C., et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12 (1997), 1908–1915.
11. 11 Miller, M., Stone, N.J., Ballantyne, C., et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123 (2011), 2292–2333.
12. 12 de Boer, I.H., Astor, B.C., Kramer, H., et al. Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 3 (2008), 125–132.
13. 13 Rhee, E.P., Cheng, S., Larson, M.G., et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121 (2011), 1402–1411.
14. 14 Dutta, T., Chai, H.S., Ward, L.E., et al. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes 61 (2012), 1004–1016.
15. 15 Hinterwirth, H., Stegemann, C., Mayr, M., Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease. Circ Cardiovasc Genet 7 (2014), 941–954.
16. 16 Zhou, X., Mao, J., Ai, J., et al. Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS One, 7, 2012, e48889.
17. 17 Sas, K.M., Karnovsky, A., Michailidis, G., Pennathur, S., Metabolomics and diabetes: analytical and computational approaches. Diabetes 64 (2015), 718–732.
18. 18 Reis, A., Rudnitskaya, A., Chariyavilaskul, P., et al. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. J Lipid Res 56 (2015), 413–422.
19. 19 Jassim, F.A., Image denoising using interquartile range filter with local averaging. Int J Soft Comput Eng 2 (2013), 2231–2307.
20. 20 Feldman, H.I., Appel, L.J., Chertow, G.M., et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 14 (2003), S148–S153.
21. 21 Lash, J.P., Go, A.S., Appel, L.J., et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4 (2009), 1302–1311.
22. 22 Altman, N.S., An introduction to kernel and nearest-neighbor nonparametric regression. Am Stat 46 (1992), 175–185.
23. 23 Redestig, H., Fukushima, A., Stenlund, H., et al. Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data. Anal Chem 81 (2009), 7974–7980.
24. 24 Storey, J.D., Tibshirani, R., Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100 (2003), 9440–9445.
25. 25 Benjamini, Y., Drai, D., Elmer, G., et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125 (2001), 279–284.
26. 26 Eriksson, L., Antti, H., Gottfries, J., et al. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem 380 (2004), 419–429.
27. 27 Eriksson, L., Johansson, E., Lindgren, F., et al. Megavariate analysis of hierarchical QSAR data. J Comput Aided Mol Des 16 (2002), 711–726.
28. 28 Svetnik, V., Liaw, A., Tong, C., et al. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 43 (2003), 1947–1958.
29. 29 DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988), 837–845.
30. 30 Karnovsky, A., Weymouth, T., Hull, T., et al. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics 28 (2012), 373–380.
31. 31 Jankova J, van de Geer S. Honest confidence regions and optimality in high-dimensional precision matrix estimation. Available at: https://arxiv.org/pdf/1507.02061v2.pdf. Accessed September 8, 2016.
32. 32 Hanley, J.A., McNeil, B.J., A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983), 839–843.
33. 33 Obuchowski, N.A., McClish, D.K., Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med 16 (1997), 1529–1542.
34. 34 Xia, J., Mandal, R., Sinelnikov, I.V., et al. MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis. Nucleic Acids Res 40 (2012), W127–W133.
35. 35 Xia, J., Psychogios, N., Young, N., Wishart, D.S., MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37 (2009), W652–W660.
36. 36 De Livera AM, Bowne JB. Package ‘Metabolomics’. Available at: https://cran.r-project.org/web/packages/metabolomics/metabolomics.pdf. Accessed September 8, 2016.
37. 37 Miller, E.R. III, Juraschek, S.P., Anderson, C.A., et al. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial. Diabetes Care 36 (2013), 1462–1469.
38. 38 Miller, E.R. 3rd, Juraschek, S.P., Appel, L.J., et al. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am J Clin Nutr 89 (2009), 1937–1945.
39. 39 Carmen, G.Y., Victor, S.M., Signalling mechanisms regulating lipolysis. Cell Signal 18 (2006), 401–408.
40. 40 Mehta, K.D., Radominska-Pandya, A., Kapoor, G.S., et al. Critical role of diacylglycerol- and phospholipid-regulated protein kinase C epsilon in induction of low-density lipoprotein receptor transcription in response to depletion of cholesterol. Mol Cell Biol 22 (2002), 3783–3793.
41. 41 Reibman, J., Korchak, H.M., Vosshall, L.B., et al. Changes in diacylglycerol labeling, cell shape, and protein phosphorylation distinguish “triggering” from “activation” of human neutrophils. J Biol Chem 263 (1988), 6322–6328.
42. 42 van Dijk, M., Muriana, F.J., van Der Hoeven, P.C., et al. Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: dependence on protein kinase C-zeta. Biochem J 323:Pt 3 (1997), 693–699.
43. 43 Yamamoto, H., Hanada, K., Nishijima, M., Involvement of diacylglycerol production in activation of nuclear factor kappaB by a CD14-mediated lipopolysaccharide stimulus. Biochem J 325:Pt 1 (1997), 223–228.
44. 44 Baldanzi, G., Mitola, S., Cutrupi, S., et al. Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. Oncogene 23 (2004), 4828–4838.
45. 45 Yang, L., Xu, Y., Li, W., et al. Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model. J Mol Neurosci 56 (2015), 78–88.
46. 46 Maehira, F., Harada, K., Shimoji, J., et al. Age-related changes in the activation of aortic cholesteryl ester hydrolases by protein kinases in rats. Biochim Biophys Acta 1389 (1998), 197–205.
47. 47 Mei, S., Gu, H., Ward, A., et al. p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy. J Biol Chem 287 (2012), 11761–11768.
48. 48 Bazzi, M.D., Youakim, M.A., Nelsestuen, G.L., Importance of phosphatidylethanolamine for association of protein kinase C and other cytoplasmic proteins with membranes. Biochemistry 31 (1992), 1125–1134.
49. 49 Cook, H.W., Ridgway, N.D., Byers, D.M., Involvement of phospholipase D and protein kinase C in phorbol ester and fatty acid stimulated turnover of phosphatidylcholine and phosphatidylethanolamine in neural cells. Biochim Biophys Acta 1390 (1998), 103–117.
50. 50 Kiss, Z., Cooperative effects of ethanol and protein kinase C activators on phospholipase-D-mediated hydrolysis of phosphatidylethanolamine in NIH 3T3 fibroblasts. Biochim Biophys Acta 1175 (1992), 88–94.
51. 51 Kiss, Z., The long-term combined stimulatory effects of ethanol and phorbol ester on phosphatidylethanolamine hydrolysis are mediated by a phospholipase C and prevented by overexpressed alpha-protein kinase C in fibroblasts. Eur J Biochem 209 (1992), 467–473.
52. 52 Kiss, Z., Expression of protein kinase C-beta promotes the stimulatory effect of phorbol ester on phosphatidylethanolamine synthesis. Arch Biochem Biophys 347 (1997), 37–44.
53. 53 Sesca, E., Perletti, G.P., Binasco, V., et al. Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth. Biochem Biophys Res Commun 229 (1996), 158–162.
54. 54 Tomono, M., Kiss, Z., Vitamin K3 preferentially inhibits stimulation of phospholipase D-mediated hydrolysis of phosphatidylethanolamine by protein kinase C activators in NIH 3T3 fibroblasts. Arch Biochem Biophys 314 (1994), 217–223.
55. 55 Eros, G., Varga, G., Varadi, R., et al. Anti-inflammatory action of a phosphatidylcholine, phosphatidylethanolamine and N-acylphosphatidylethanolamine-enriched diet in carrageenan-induced pleurisy. Eur Surg Res 42 (2009), 40–48.